Chris Preston is an investment analyst and web content editor for the Cabot Wealth Network website. He is also a news writer for Cabot’s free Wall Street’s Best Daily e-newsletter, and contributes to other Cabot advisories and special projects. Chris was previously an analyst and assistant managing editor with Wyatt Investment Research. He has been a professional writer for over 10 years, picking up two writing awards along the way.
Articles by Chris Preston
Million-dollar homes paid for by one stock, wine in a can, and sailing in a thunderstorm were among the highlights from last week's Cabot Wealth Summit.
Business development companies are a high-risk, high-reward proposition for income investors. But there are ways to mitigate the risks.
After two months of churn, biotech stocks are suddenly red-hot thanks to a blockbuster Gilead-Kite Pharma deal that's propping up the entire sector.